Abbott Laboratories (ABT) stock saw a decline, ending the day at $114.88 which represents a decrease of $-3.25 or -2.75% from the prior close of $118.13. The stock opened at $117.5 and touched a low ...

In recent trading, SenesTech Inc (SNES) stock price has shown some volatility, fluctuating -14.64% over the last five trades and -36.59% over the past 30 trades. This represents a notable shift from ...

Organon & Co (OGN) stock saw a decline, ending the day at $19.97 which represents a decrease of $-0.58 or -2.82% from the prior close of $20.55. The stock opened at $20.51 and touched a low of $19.42 ...

Exelixis Inc (EXEL) stock saw a decline, ending the day at $26.82 which represents a decrease of $-0.78 or -2.83% from the prior close of $27.6. The stock opened at $27.66 and touched a low of $26.56 ...

Fate Therapeutics Inc (FATE) stock saw a decline, ending the day at $3.88 which represents a decrease of $-0.12 or -3.00% from the prior close of $4. The stock opened at $3.95 and touched a low of $3.

Aehr Test Systems (AEHR) stock saw a decline, ending the day at $12.1 which represents a decrease of $-0.37 or -2.97% from the prior close of $12.47. The stock opened at $12.61 and touched a low of ...

As of now, Galmed Pharmaceuticals has shown a remarkable year-to-date performance of +85.14%. In comparison, the S&P 500 has returned +19.90% over the same period. This stark contrast highlights ...

Moderna Inc (MRNA) stock saw a decline, ending the day at $69.86 which represents a decrease of $-2.13 or -2.96% from the prior close of $71.99. The stock opened at $72.19 and touched a low of $69.82 ...

Alaska Air Group, Inc. (ALK) stock saw a decline, ending the day at $39.76 which represents a decrease of $-1.22 or -2.98% from the prior close of $40.98. The stock opened at $41.08 and touched a low ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 15.03% ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 46.48% ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 70.45% ...